Kenneth Ng Email and Phone Number
Kenneth Ng work email
- Valid
- Valid
- Valid
Kenneth Ng personal email
Passionate healthcare strategist and market access expert with demonstrated success in executive leadership and business development across start-up and established advertising agencies. Broad range of expertise spanning multiple therapeutic areas including cardiovascular, cosmetic dermatology, gastroenterology, immunology, neurology, oncology, orthopedics, pain management, psychiatry, renal disease, rheumatology, and surgery/medical devices. Experienced with employee management, inspirational coaching, managing team dynamics, and remote work situations.
Nexus Health Group™
View- Employees:
- 17
-
Nexus Health Group™Portland, Or, Us -
Vice President, Group Scientific Director (Market Access)Lockwood Jul 2024 - PresentStamford, Ct, Us• Currently managing copy and content development for a start-up market access platform within the established Lockwood medical marketing group• Providing strategic communication insights and action plans for established products in asthma/COPD, mental health, and thyroid eye disease• Developing pre-approval information exchange and payer value proposition materials (field presentations, brochures/leave-behinds, websites) for launch brands in neuro-oncology -
Senior Scientific Director, Team Lead (Market Access)Lockwood Apr 2023 - Jul 2024Stamford, Ct, Us• Led content development efforts for 3 pharmaceutical brands (1 in rare eye disease, 1 in COPD, 1 for bipolar/schizophrenia), including the creation of payer value propositions, clinical monographs, payer disease state presentations, and market research materials• Developed preapproval information exchange (PIE) communications for 2 oncology products in glioma and hematological cancers (AML, MDS), highlighting the critical clinical data to key US payer targets• Facilitated high-value, face-to-face engagement between pharma marketers and payer thought-leaders through multiple live and virtual advisory activities across different therapeutic areas -
Senior Scientific Director, Team Lead (Medical Marketing/Communications)Lockwood Sep 2018 - Apr 2023Stamford, Ct, Us• Led the scientific team for 5 pharmaceutical brands: 3 mature brands in inflammatory disease, 1 mature brand in an ultra-rare immunodeficiency (<1000 patients), and 1 new product in commercial development for a rare, inflammatory disease• Engaged HCPs for virtual advisory activities across live and asynchronous (offline) platforms• Launched virtual peer-to-peer education programs for 4 different brands during COVID-19 shutdown, enabling continued HCP engagement in absence of live speaker events• Stabilized volume and revenue of 3 end-of-lifecycle pharmaceuticals by refocusing existing marketing/education tactics from physicians to advanced practice providers (ie, RN, NP, PAs)• Successfully launched a blockbuster biologic therapy in thyroid eye disease ($800MM FY2020, $1.6BB FY2021), including an intensive “advisory board road show” that delivered launch-critical strategy and insights• Active in new business development, helping to pitch/win 3 accounts ($2.2MM revenue) in FY2019 -
Vice President, Director Of Medical Strategy (Market Access & Regulatory)Provaluate Jan 2016 - Jul 2018• Led as an executive leader and Chief Scientific Officer of a startup, market access agency • Identified 7 high-priority business leads, leading to 3 account wins, & $1.2MM revenue in 2016-17• Pitched and won a $2.4 MM oncology portfolio, representing 36% of 2018 company revenue• Created business targeting process within the company, increasing potential client leads by 200%• Drove social media marketing efforts, resulting in a top 10 Google ranking for company website (formerly Choreo Market Access)• Developed data release strategy for mRNA and cancer vaccine start-up that increased client visibility and enabled a successful $100MM+ IPO• Coached vaccine regulatory team to unanimous positive FDA AdComm vote and marketing approval (GSK Shingrix)• Created payer launch campaigns for a novel ADF opioid and a SHPT medication, contributing to broad commercial and Medicare Part D coverage within 6 months of launch (>50% of covered lives each)• Managed value proposition development and deliverables for 3 drugs in chronic lymphocytic leukemia, small-cell lung cancer, and glioblastoma multiforme• Started inter-agency training and blogging initiatives on relevant payer subjects, including FDAMA 114, CFL guidance, co-pay assistance programs, and PBM/SPP channel strategy
-
Research FellowHospital For Special Surgery Sep 2008 - Jul 2011New York, Ny, Us• Invented a patented polymer scaffold for the repair of cartilage lesions (currently in pre-clinical animal trials)• Created drug delivery microparticle and scaffold coating technologies to improve healing from musculoskeletal injuries• Managed teams comprised of orthopedic surgeons, students (medical, graduate, undergraduate), and volunteers (including visiting international Surgeon-in-Chief) to spearhead scientific research projects• Awarded $100,000 from the National Institutes of Health, Bethesda, MD to develop a novel processing method for soft tissues used to reconstruct torn anterior cruciate ligaments -
Associate Scientific AdvisorScience Magazine Jan 2010 - Feb 2011Washington, Dc, Us• Served on editorial board as Key Opinion Leader for Science Translational Medicine to evaluate breakthroughs in scientific literature and determine journal policy and content• Wrote 19 popular science articles (“Editor’s Choice”) to highlight exciting scientific discoveries and foster improved collaboration/communication between scientists, doctors, and the general public• Article topics: Stem cells, cancer, diabetes, cardiovascular stents, drug delivery, orthopedics, tissue engineering -
Post-Doctoral Research ScientistColumbia University Oct 2007 - Aug 2008New York, Ny, Us• Job functions/research performed jointly with Dr. James L. Cook at the University of Missouri - Columbia• Developed the _first_ engineered canine cartilage constructs with 100% of the native tissue properties for large-animal, tissue engineering trials in a clinically relevant, adult canine model (FDA large animal model)• Collaborated with veterinary surgeons at University of Missouri to develop tissue engineered construct (focal and patella) implantation and retrieval techniques• Awarded a $40,000 industry grant from Integra Life Sciences to determine the failure mechanisms of the Achillon, a novel Achilles tendon repair device (in collaboration with orthopedic surgeons at St. Luke’s – Roosevelt Hospital Center) -
Graduate Research AssociateColumbia University Sep 2001 - Sep 2007New York, Ny, Us• Developed the _first_ layered scaffold system to fabricate a biomimetic engineered cartilage construct with both prescribed mechanical inhomogeneity and zonal chondrocyte populations• Developed and evaluated strategies for improved mechanical and matrix properties in engineered cartilage: Transient application of anabolic growth factors (TGF-β1, TGF-β3, or IGF-I), increasing amino acid supply, collagen hydrolysate supplementation, controlled scaffold degradation• Co-developed surgical procedures for a novel, in vivo, loading bioreactor utilizing the intervertebral disc (IVD) space of a rat tail• Studied the effects of surgical implantation and loading on the properties of tissue engineered cartilage implanted into the IVD space of a rat tail• Collaborated with the Department of Orthopaedic Surgery, St. Luke’s – Roosevelt Hospital Center, New York, NY to develop an intensive, 2-month, research rotation program for surgical residents• Managed and mentored 6 orthopedic surgical residents and 5 undergraduate students in scientific research -
Technical ConsultantColumbia University Jun 2000 - Jan 2003New York, Ny, Us• Developed website for Administrative Information Services (AIS) utilizing Adobe Flash, Photoshop, and ColdFusion software• Provided IT technical support for networking, desktop systems, and internal and external applications for data management
Kenneth Ng Skills
Kenneth Ng Education Details
-
Joan & Sanford I. Weill Medical College Of Cornell UniversityClinical And Translational Investigation -
Columbia UniversityBiomedical Engineering -
Columbia UniversityBiomedical Engineering -
Columbia EngineeringBiomedical Engineering -
Columbia EngineeringBiomedical Engineering -
Stuyvesant High School
Frequently Asked Questions about Kenneth Ng
What company does Kenneth Ng work for?
Kenneth Ng works for Nexus Health Group™
What is Kenneth Ng's role at the current company?
Kenneth Ng's current role is Passionate healthcare and market access strategist.
What is Kenneth Ng's email address?
Kenneth Ng's email address is kn****@****grp.com
What schools did Kenneth Ng attend?
Kenneth Ng attended Joan & Sanford I. Weill Medical College Of Cornell University, Columbia University, Columbia University, Columbia Engineering, Columbia Engineering, Stuyvesant High School.
What skills is Kenneth Ng known for?
Kenneth Ng has skills like Medical Devices, Clinical Research, Pharmaceutical Industry, Bioengineering, Biomedical Engineering, Medical Education, Cancer, Marketing, Medicine, Healthcare Marketing, Clinical Development, Tissue Engineering.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial